The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
The company has posted net profit of Rs.155.85 crores for the period ended March 31, 2021
During the three months ended March 31, 2021, the company spent $98 million on capital expenditures as compared to $61 million in the same period of 2020
With no significant planned maintenance for our assets during the second quarter, we plan to operate at nearly full capacity worldwide to meet robust demand
The company posted net profit of Rs.175.05 crores for the period ended March 31, 2021
WACKER performed very well in Q1 2021
This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis
The company has continuously been reviewing its engagements to move up higher in the value chain
Cash flow from operating activities of $9.3 billion fully funded dividend and capital expenditures, and drove debt reduction of over $4 billion
Completed a planned turnaround at the Geismar 2 plant and expects to complete the Geismar 2 debottlenecking project by mid-2021.
Acquisition will enable accelerated growth of key animal nutrition markets
Sales revenue from chemical intermediates increased 2% driven by a 14% increase in selling prices
The iGRP segment reported adjusted net operating income of $1 billion, the highest in its history
The share of petrochemicals in SIBUR’s EBITDA structure reached a record 65.6%
SABIC’s LEXAN polycarbonate resin can potentially result in reductions in carbon footprint of up to 61% and fossil depletion reduction of up to 35%
Investments in chemical recycling with partners like Borealis are critical to Berry
EBITDA of CHF 164 million rose by 4 % in Swiss francs, generating a notably improved EBITDA margin at 16.4 % (vs. 15.4 %)
For every 100 kg of LNP compound, 21 kg of fossil-based materials have been replaced with bio-based materials
The company has achieved robust EBITDA growth of 21%, the EBITDA for the quarter stood at Rs. 195 crores as compared to Rs. 161 crores in the corresponding quarter last year
The company has scored 68 out of 100 which places the company in the top 5% of all companies assessed under the worldwide rating system
Subscribe To Our Newsletter & Stay Updated
